Related Experiment Video
Updated: Mar 17, 2026

08:48
Peptide-derived Method to Transport Genes and Proteins Across Cellular and Organellar Barriers in Plants
Published on: December 16, 2016
11.1K
Synthesis of pH-Cleavable dPG-Amines for Gene Delivery Application
Mathias Dimde1, Dirk Steinhilber1, Falko Neumann1
1Institute of Chemistry and Biochemistry, Freie Universität Berlin, Takustrasse 3, Berlin, 14195, Germany.
Macromolecular Bioscience
|July 20, 2016
Summary
Researchers developed novel pH-cleavable polyglycerol-amine nanocarriers for gene therapy. These nonviral vectors show reduced toxicity and enable controlled genetic material release, addressing key challenges in the field.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Gene Therapy
Background:
- Nonviral vectors are crucial for gene therapy, but many polycationic nanocarriers exhibit high toxicity.
- Developing effective and less toxic nonviral vectors remains a significant research challenge.
Purpose of the Study:
- To develop novel pH-cleavable polyglycerol-amine-based nanocarriers for gene therapy applications.
- To investigate the toxicity, degradation, and transfection capabilities of these new nanocarriers.
Main Methods:
- Synthesis of two pH-cleavable polyglycerol-amine nanocarriers utilizing a benz-acetal linkage.
- In vitro assessment of nanocarrier toxicity and cell-mediated degradation.
- Evaluation of genetic material release kinetics at endosomal pH.
- In vitro transfection of HeLa cells with GFP-DNA using the developed nanocarriers.
Main Results:
- The cleavable polyglycerol-amine nanocarriers demonstrated reduced in vitro toxicity compared to conventional polycationic vectors.
- Cell-mediated degradation yielded non-toxic, low molecular weight products.
- Genetic material release was observed due to the loss of multivalent amine groups.
- Transfection efficiency in HeLa cells with GFP-DNA was successfully demonstrated.
Conclusions:
- pH-cleavable polyglycerol-amine nanocarriers offer a promising alternative for gene therapy due to their reduced toxicity and tunable release properties.
- The acid-labile benz-acetal bond facilitates controlled degradation and genetic material release within the cellular environment.
- Further development of these nanocarriers could significantly advance nonviral gene delivery strategies.
More Related Videos
Related Concept Videos
Gene Therapy
28.0K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
28.0K
Preparation of 1° Amines: Gabriel Synthesis
4.9K
Direct alkylation is not a suitable method for synthesizing amines because it produces polyalkylated products. Gabriel synthesis is the most preferred method to exclusively make primary amines. The method uses phthalimide, which contains a protected form of nitrogen that participates in alkylation only once to predominantly give primary amines.
Strong bases like NaOH or KOH deprotonate the phthalimide to form the corresponding anion, which acts as a nucleophile. Further, the anion attacks an...
Strong bases like NaOH or KOH deprotonate the phthalimide to form the corresponding anion, which acts as a nucleophile. Further, the anion attacks an...
4.9K
Site-Targeted Drug Delivery Systems: Polymeric Carriers
82
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
82

